E-Book, Englisch, 540 Seiten
Reihe: Clinical Gastroenterology
Shami / Kahaleh Endoscopic Ultrasound
1. Auflage 2010
ISBN: 978-1-60327-480-7
Verlag: Humana Press
Format: PDF
Kopierschutz: 1 - PDF Watermark
E-Book, Englisch, 540 Seiten
Reihe: Clinical Gastroenterology
ISBN: 978-1-60327-480-7
Verlag: Humana Press
Format: PDF
Kopierschutz: 1 - PDF Watermark
Autoren/Hrsg.
Weitere Infos & Material
1;Endosonographic Instrumentation;13
1.1;INTRODUCTION: BASICS OF ULTRASOUND AND RATIONALE FOR EUS;14
1.2;THE ULTRASOUND TRANSDUCER;15
1.3;RADIAL ARRAY VERSUS LINEAR ARRAY;15
1.4;BASIC ECHOENDOSCOPE DESIGN;18
1.5;LINEAR ARRAY ECHOENDOSCOPES;20
1.6;RADIAL ECHOENDOSCOPES;20
1.7;ENDOBRONCHIAL ULTRASOUND DEVICES;25
1.8;OTHER SPECIALIZED DEVICES;27
1.9;EUS MINIPROBES;31
1.10;ULTRASOUND CONSOLES;31
1.11;EUS NEEDLES;36
1.12;CONCLUSION;40
1.13;REFERENCES;41
2;Probe Ultrasonography;42
2.1;INTRODUCTION;43
2.2;INSTRUMENTS AND EXAMINATION TECHNIQUES;44
2.3;GASTROINTESTINAL WALL ANATOMY;45
2.4;CLINICAL INDICATIONS;47
2.4.1;Esophagus;47
2.4.2;Stomach;47
2.4.3;Small Bowel and Colon;51
2.5;INTRADUCTAL ULTRASOUND;55
2.6;TECHNICAL CONSIDERATIONS;55
2.7;BILIARY TRACT ANATOMY;55
2.8;CLINICAL INDICATIONS;56
2.8.1;Choledocholithiasis;56
2.8.2;Bile Duct Strictures;57
2.8.3;Cholangiocarcinoma;57
2.9;PANCREATIC INTRADUCTAL ULTRASOUND;59
2.9.1;Pancreatic Duct Strictures and Pancreatic Adenocarcinoma;59
2.9.2;Mucin-Producing and Islet-Cell Tumors;59
2.10;PAPILLA OF VATER INTRADUCTAL ULTRASOUND;60
2.11;FUTURE PROBE TECHOLOGY;60
2.12;CONCLUSION;61
2.13;REFERENCES;62
3;Radial Endoscopic Ultrasound;71
3.1;INTRODUCTION;72
3.2;EQUIPMENT;73
3.3;GASTROINTESTINAL TRACT WALL;77
3.4;MEDIASTINUM AND ESOPHAGUS;78
3.4.1;Distal Esophagus;78
3.4.2;Midesophagus;80
3.4.3;Proximal Esophagus;83
3.5;STOMACH;83
3.6;PANCREAS AND EXTRAHEPATIC BILE DUCT;87
3.7;RECTUM;92
3.8;SUMMARY;96
3.9;REFERENCES;97
4;Linear Endoscopic Ultrasound;98
4.1;INTRODUCTION;99
4.2;TECHNIQUE;99
4.2.1;Maneuvering the Linear Echoendoscope;99
4.2.2;Value of a Forward Viewing Endoscopy Prior to EUS;101
4.2.3;Mediastinum;101
4.2.4;Celiac Axis and Adjacent Structures;103
4.2.5;Liver and Gallbladder;105
4.2.6;Pancreas, Bile Duct, and Ampulla;106
4.2.7;Rectum;109
4.3;ACCESSORIES;109
4.3.1;Balloons;109
4.3.2;Buttons and Caps;109
4.4;Role of linear eus in Gi diseases;110
4.4.1;Esophageal Cancer;110
4.4.2;Stomach Cancer;111
4.4.3;Pancreatic Cancer;112
4.4.4;Chronic Pancreatitis and Pancreatic Ductal Anatomy;113
4.4.5;Common Bile Duct Stones;114
4.4.6;Rectal Cancer;115
4.5;SUMMARY;115
4.6;REFERENCES;115
5;The Cytopathology of Endoscopic Ultrasound-Guided Fine Needle Aspiration;118
5.1;INTRODUCTION;119
5.2;PRINCIPLES OF CYTOLOGY;119
5.2.1;Preparations;119
5.3;TERMINOLOGY;121
5.4;BIOPSY OF LUMINAL GUT;122
5.4.1;Epithelial Malignancy;122
5.4.1.1;Adenocarcinoma;122
5.4.1.2;Squamous cell carcinoma;124
5.4.1.3;Spindle cell (sarcomatoid) carcinoma;125
5.4.1.4;Carcinoid tumors and other well-differentiated neuroendocrine carcinomas;126
5.4.2;Mesenchymal Neoplasia;128
5.4.3;Lymphoma;132
5.4.4;Melanoma;135
5.4.5;Other Lesions;137
5.5;BIOPSY OF LYMPH NODES;138
5.5.1;The Staging of Malignancy;138
5.5.2;Adenopathy of Other Etiology;138
5.6;BIOPSY OF THE LUNG AND MEDIASTINUM;140
5.7;BIOPSY OF THE PANCREAS, EXTRAHEPATIC BILIARY SYSTEM, AND GALLBLADDER;144
5.7.1;Pancreas;144
5.7.1.1;Pancreatic ductal adenocarcinoma;146
5.7.1.2;Other primary pancreatic solid neoplasms;148
5.7.1.3;Solid lesions mimicking solid pancreatic neoplasia;152
5.7.1.4;Cystic lesions;154
5.7.2;Extrahepatic Biliary System and Gallbladder;159
5.8;BIOPSY OF THE LIVER;159
5.9;ADRENAL GLAND;161
5.10;CONCLUSION;162
5.11;REFERENCES;162
6;Pitfalls in Endoscopic Ultrasound;171
6.1;SEDATION;172
6.2;ENDOSCOPE INTUBATION AND PASSAGE;172
6.3;ORIENTATION;173
6.4;TECHNICAL ISSUES;177
6.5;EUS INDICATIONS;178
6.6;EQUIPMENT SELECTION;179
6.7;FNA CONSIDERATIONS;180
6.8;Sec8_6;181
6.9;CONCLUSION;184
6.10;REFERENCES;184
7;The Role of EUS in Esophageal Cancer;188
7.1;INTRODUCTION;189
7.2;DIAGNOSIS;189
7.3;STAGING ESOPHAGEAL CANCER;189
7.4;T STAGING;192
7.5;N STAGING;196
7.5.1;Staging in the Setting of Malignant Strictures;199
7.6;M STAGING;200
7.7;RESTAGING;201
7.8;DETECTING TUMOR RECURRENCE;202
7.9;BARRETT’S ESOPHAGUS;203
7.10;QUALITY INDICATORS;203
7.11;CONCLUSION;204
7.12;REFERENCES;204
8;Role of EUS in Mediastinal Nodes, Masses, Cysts, and Lung Cancer;209
8.1;INTRODUCTION;210
8.1.1;Mediastinal Cysts;211
8.2;ROLE OF FNA;212
8.3;THE LUNG MASS;212
8.4;LUNG CANCER;214
8.5;RATIONALE FOR EUS;214
8.6;BEFORE YOU START;215
8.7;WHICH TEST IS BEST?;217
8.8;CROSS-SECTIONAL IMAGING;218
8.9;FUNCTIONAL IMAGING;219
8.10;FAILED BRONCHOSCOPY AND EUS RESCUE;220
8.11;EUS AND MEDIASTINOSCOPY;220
8.12;MEDICAL MEDIASTINOSCOPY;220
8.13;ENDOBRONCHIAL ULTRASOUND;220
8.14;SHOULD EUS BE EMPLOYED IN SUSPECTED EARLY LUNG CANCER?;222
8.15;THE LINEAR EXAM;222
8.16;THE FNA TECHNIQUE;222
8.17;SELECTIVE NODAL TARGETING;224
8.18;DOES EUS PREDICT T4 DISEASE?;225
8.19;EUS AFTER INDUCTION THERAPY;225
8.20;NEW APPLICATIONS;226
8.21;COST EFFECTIVENESS OF EUS IN LUNG CANCER;226
8.22;TRAINING;226
8.23;CONCLUSION;227
8.24;References;227
9;The Role of Endoscopic Ultrasound in Gastric Cancer;231
9.1;INTRODUCTION;232
9.2;GASTRIC CANCER STAGING SYSTEMS;233
9.3;DIAGNOSIS AND STAGING OF GASTRIC CANCER;235
9.4;EUS TECHNIQUE;235
9.5;PRIMARY TUMOR ASSESSMENT (T-STAGE) OF GASTRIC CANCER BY EUS;237
9.6;LYMPH NODE ASSESSMENT (N-STAGING) OF GASTRIC CANCER BY EUS;240
9.7;ASSESSMENT OF DISTANT METASTASES (M-STAGING) OF GASTRIC CANCER BY EUS;242
9.8;TECHNICAL LIMITATIONS OF EUS FOR TNM STAGING OF GASTRIC CANCER;242
9.9;COMPARISON OF EUS TO OTHER IMAGING MODALITIES FOR STAGING OF GASTRIC CANCER;243
9.10;EUS IN THE EVALUATION OF EARLY GASTRIC CANCER;243
9.11;EUS IN THE EVALUATION OF LOCALLY ADVANCED GASTRIC CANCER;245
9.12;CONCLUSION;246
9.13;REFERENCES;247
10;The Role of EUS in Subepithelial Lesions;252
10.1;INTRODUCTION;252
10.2;EXTRAMURAL LESIONS;254
10.3;INTRAMURAL LESIONS;255
10.3.1;Benign;255
10.3.1.1;Lipoma;255
10.3.1.2;Leiomyoma;257
10.3.1.3;Varices;259
10.3.1.4;Pancreatic Rest;259
10.3.1.5;Duplication Cyst;261
10.3.1.6;Inflammatory Fibroid Polyp;261
10.3.2;Malignant or Premalignant;262
10.3.2.1;Gastrointestinal Stromal Tumor;262
10.3.2.2;Carcinoid Tumor;262
10.3.2.3;Lymphoma;264
10.3.2.4;Glomus Tumors;264
10.3.2.5;Granular Cell Tumors;264
10.3.2.6;Metastasis;265
10.4;CONCLUSIONS;265
10.5;REFERENCES;265
11;Endoscopic Ultrasound of Ampullary and Duodenal Lesions;270
11.1;INTRODUCTION;271
11.2;AMPULLA OF VATER;271
11.2.1;Benign Lesions of the Ampulla of Vater;271
11.2.2;Malignant Lesions of the Ampulla of Vater;272
11.2.3;Lesions Involving the Minor Duodenal Ampulla;273
11.3;TECHNIQUE OF EUS EXAMINATION;273
11.3.1;EUS-Guided FNA;274
11.3.2;Intraductal Ultrasound;274
11.4;STAGING ACCURACY OF EUS;277
11.5;TREATMENT;280
11.6;DUODENAL LESIONS;280
11.6.1;Benign Lesions of the Duodenum;281
11.7;CONCLUSIONS;281
11.8;REFERENCES;282
12;The Role of EUS in Pancreatic Cancer;286
12.1;Introduction;287
12.2;PRESENTATION AND INITIAL EVALUATION;287
12.3;RADIOGRAPHIC IMAGING STUDIES;292
12.4;ENDOSCOPIC ULTRASOUND (EUS);292
12.5;REFERENCES;298
13;The Role of EUS in Cystic Lesions of the Pancreas;302
13.1;INTRODUCTION;303
13.2;EUS VERSUS OTHER IMAGING MODALITIES IN THE DIAGNOSIS OF CPLs;304
13.3;EUS-FNA of CPLs: TECHNIQUE;306
13.4;EUS-GUIDED TRUCUT BIOPSIES;307
13.5;CYST FLUID EVALUATION;308
13.5.1;Cytology;308
13.5.2;Tumor Markers;309
13.5.3;Genetic Markers;310
13.6;SEROUS CYSTIC NEOPLASMS;311
13.7;MUCINOUS CYSTIC NEOPLASMS;313
13.8;INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS;316
13.9;OTHER RARE TYPES OF CPLs;320
13.10;TREATMENT OF CPLs;322
13.10.1;Expectant Management;322
13.10.2;Surgical Management;323
13.10.3;Alternate Nonsurgical Management and Future Developments;323
13.11;CONCLUSION;324
13.12;REFERENCES;324
14;The Role of EUS in the Biliary System;331
14.1;TECHNIQUE OF BILIARY IMAGING;332
14.1.1;Standard Endoscopic Ultrasonography;332
14.1.2;Intraductal Ultrasonography;335
14.1.3;Normal Findings;337
14.2;GALLSTONE DISEASE;338
14.2.1;Introduction;338
14.2.2;Technique;339
14.2.3;Results;340
14.2.4;Particular Case: “Idiopathic” Acute Pancreatitis;344
14.3;BILIARY STRICTURES;346
14.3.1;Standard Endoscopic Ultrasonography;346
14.3.1.1;Detection and Characterization of Biliary Strictures and Lymph Nodes;346
14.3.1.2;Sampling;347
14.3.1.3;Longitudinal Tumor Extent, TNM Stage, and Resectability;350
14.3.1.4;Impact of EUS-FNA on Patient Management;352
14.3.2;Intraductal Ultrasonography;354
14.3.2.1;Introduction;354
14.3.2.2;Distinction Between Benign and Malignant Strictures;354
14.3.2.3;Staging of Cholangiocarcinomas;355
14.3.3;Particular Case: Primary Sclerosing Cholangitis;356
14.3.4;Therapeutic EUS for Biliary Strictures;357
14.3.4.1;Preamble;357
14.3.4.2;Technique;358
14.3.4.3;Results;358
14.4;GALLBLADDER;358
14.4.1;Normal Findings;358
14.4.2;Stones;358
14.4.3;Polypoid Lesions;359
14.4.3.1;Description;359
14.4.3.2;Role of EUS in the Management of Gallbladder Polypoid Lesions;360
14.4.4;Carcinoma;361
14.5;REFERENCES;364
15;The Role of EUS in Rectal Cancer and Fecal Incontinence;373
15.1;EUS AND RECTAL CANCER;374
15.1.1;Background;374
15.1.2;EUS Technique;374
15.1.3;T Staging;374
15.1.4;N Staging;377
15.1.5;Fine Needle Aspiration;377
15.1.6;Clinical Significance of EUS in Rectal Cancer Staging;380
15.1.7;Factors Affecting EUS Accuracy;380
15.1.8;Tumor Recurrence;380
15.1.9;Future EUS Applications in Rectal Cancer;381
15.2;EUS AND FECAL INCONTINENCE;381
15.2.1;Background;381
15.2.2;Normal Anatomy of the Anal Sphincter;382
15.2.3;EUS Technique;382
15.2.4;EUS Accuracy in Identifying Sphincter Tears;383
15.2.5;EUS Compared to Other Modalities;384
15.2.6;Clinical Impact of EUS on Fecal Incontinence;384
15.2.7;Future EUS Applications in Fecal Incontinence;385
15.3;SUMMARY;385
15.4;References;386
16;Interventional Endoscopic Ultrasound-Guided Cholangiopancreatography;392
16.1;INTRODUCTION;393
16.1.1;Patient Selection;393
16.1.2;Endoscopist Selection;394
16.1.3;Patient Preparation;394
16.1.4;Techniques;394
16.1.4.1;EUS-guided Biliary Drainage;395
16.1.4.1.1;Intrahepatic Approach;395
16.1.4.1.2;Extrahepatic Approach;396
16.1.4.2;EUS-guided pancreatic drainage;398
16.2;LITERATURE REVIEW;399
16.2.1;EUS-Guided Biliary Drainage;399
16.2.2;EUS-Guided Pancreatic Drainage;401
16.3;SUMMARY;404
16.4;References;405
17;Endoscopic Ultrasound-Guided Drainage of Pancreatic Fluid Collections;409
17.1;INTRODUCTION;410
17.2;MATERIALS AND METHODS;411
17.2.1;Appropriate Candidates;411
17.2.2;Appropriate Endoscopists;411
17.2.3;Patient Preparation;411
17.2.4;Instrumentation;412
17.2.5;Predrainage Evaluation;412
17.3;PROCEDURE DESCRIPTION;412
17.4;LITERATURE REVIEW;414
17.5;CONCLUSION;420
17.6;REFERENCES;420
18;Endoscopic Ultrasound-Guided Celiac Plexus Block and Celiac Plexus Neurolysis;424
18.1;INTRODUCTION;425
18.2;ANATOMICAL AND FUNCTIONAL CONSIDERATIONS;426
18.2.1;Pancreas;426
18.3;CELIAC PLEXUS;426
18.4;TECHNIQUE;427
18.5;CPN;431
18.6;Celiac plexus block;431
18.7;PREPARATION PREPROCEDURE;432
18.8;POSTPROCEDURE MONITORING;433
18.9;SIDE EFFECTS AND COMPLICATIONS OF THE PROCEDURE;433
18.10;PROCEDURE EFFICACY;434
18.11;REFERENCES;437
19;Fine Needle Injection Therapy;441
19.1;INTRODUCTION;441
19.2;TUMOR ABLATION;442
19.2.1;Injection Therapy;443
19.2.1.1;Biologics;443
19.2.1.2;Ethanol;445
19.2.2;Thermal/Energy Delivery;447
19.2.2.1;Radiofrequency Ablation;447
19.2.2.2;Cryoablation;450
19.2.2.3;Photodynamic Therapy;452
19.2.2.4;High-Intensity Focused Ultrasound;455
19.2.3;Implantable Therapy;455
19.2.3.1;Chemotherapy;455
19.2.3.2;Brachytherapy;457
19.3;PRETREATMENT TUMOR IDENTIFICATION;459
19.3.1;Fiducial Placement;459
19.3.2;Tumor Marking;461
19.4;PANCREATIC CYST ABLATION;461
19.5;SUMMARY;463
19.6;REFERENCES;464
20;Contrast-Enhanced Endoscopic Ultrasound;473
20.1;INTRODUCTION;474
20.2;GENERAL CONSIDERATIONS;474
20.3;COMMERCIALLY AVAILABLE UCA IN EUROPE;475
20.4;PANCREATIC EUS AND US CONTRAST AGENTS;476
20.5;CONTRAST-ENHANCED EUS IN DISCRIMINATION BETWEEN BENIGN AND MALIGNANT MEDIASTINAL AND ABDOMINAL LYMPH NODES;480
20.6;CONCLUSION;481
20.7;References;482
21;Endosurgical Applications of EUS;485
21.1;INTRODUCTION;486
21.2;ENDOLUMINAL ENDOSURGICAL METHODS;487
21.2.1;EUS-Guided Pancreatic Necrosectomy;487
21.2.2;EUS-Guided Drainage of the Biliary Tract;489
21.2.3;EUS-Guided Bilioma Drainage;491
21.2.4;EUS-Guided Pancreatic Duct Interventions;491
21.2.5;EUS-Guided Vascular Interventions;492
21.3;EXPERIMENTAL EUS-GUIDED ENDOSURGERY: TOWARD NOTES;494
21.3.1;EUS-Guided Anastomosis;498
21.3.2;EUS-Guided Cardiac Interventions;499
21.4;EUS-GUIDED ENDOSURGERY;501
21.4.1;EUS-Guided Transluminal (NOTES) Access;501
21.4.2;EUS-Guided Mediastinal Drainages and NOTES;502
21.4.3;Transluminal EUS;503
21.5;CONCLUSION;503
21.6;REFERENCES;504
22;The Future of EUS;510
22.1;INTRODUCTION;510
22.2;FUTURE EUS EQUIPMENT;511
22.2.1;EUS Scopes;511
22.2.2;Future EUS Ultrasound Processors;512
22.2.3;Future EUS Accessories;512
22.3;EUS INDICATIONS IN THE FUTURE;514
22.3.1;Mediastinal EUS;514
22.3.2;Luminal GI Tract Cancer;515
22.3.3;Pancreatic Cancer;515
22.3.4;Pancreatic Cysts;516
22.3.5;EUS Pseudocyst Drainage;517
22.3.6;EUS Celiac Plexus Neurolysis;517
22.3.7;CBD Stones;518
22.3.8;Biliary Drainage;518
22.3.9;Hemostasis and Vascular EUS;518
22.3.10;EUS and NOTES/Surgery;519
22.4;FUTURE TRAINING AND QUALITY ISSUES;519
22.5;CONCLUSIONS;520
22.6;REFERENCES;521




